Background {#Sec1}
==========

Findings from cohort studies have suggested that a high degree of adherence to the Mediterranean diet is associated with a reduction in all-cause and cardiovascular (CV) mortality and CV events \[[@CR1]--[@CR33]\].

The components of the Mediterranean diet have been operationalized as a dietary score using a specific and validated score: the Mediterranean diet (MED) score \[[@CR7]\].

It is however difficult to disentangle the effects of diet from those of the risk factors for CV disease, which are increased in individuals with unhealthy diets \[[@CR34]--[@CR36]\]. Indeed, most of previous studies evaluated old subjects at high CV risk \[[@CR1]--[@CR6], [@CR8], [@CR9], [@CR11], [@CR15], [@CR16], [@CR26], [@CR28]--[@CR30], [@CR33]\]. Only few studies have excluded from the analyses individuals with pre-existing CV diseases or diabetes \[[@CR7], [@CR12], [@CR13], [@CR32]\] or included younger, healthy individuals \[[@CR10], [@CR14], [@CR16], [@CR19], [@CR20]\]. No study has explicitly considered subjects according to their CV risk.

The primary objective of this study was to assess whether the MED score was associated with all-cause mortality in individuals at low CV risk from a population-based cohort, after a 12-year mean follow-up. The secondary aim was to determine whether this score was associated with the incidence of CV events and CV mortality in the same individuals.

Patients and methods {#Sec2}
====================

Patients {#Sec3}
--------

All the 45--64 years old Caucasian patients (*n* = 1877) of six general practitioners were invited to participate in a metabolic screening in 2001--2003. These subjects were representative of the Local Health Units of the province of Asti (northwestern Italy) \[[@CR37], [@CR38]\]. Of these, 1658 (88.3 %) subjects gave their written informed consent to participate while 219 patients declined. Both the participants and non-participants were similar to the resident population of the corresponding age range in terms of male prevalence, education level, prevalence of known diabetes, and residence in a rural area \[[@CR37]\]. The study was approved by the local ethics committee. All procedures conformed to the principles of the Helsinki Declaration.

Methods {#Sec4}
-------

In the morning, after fasting, weight, height, waist circumference, and blood pressure were measured. Glucose, insulin, total cholesterol, HDL-cholesterol, triglyceride and high-sensitivity C-reactive protein (CRP) levels were determined. If the serum glucose value was ≥110 mg/dl, a second fasting glucose determination was performed. Two blood pressure measurements were made with mercury sphygmomanometers and the appropriate cuff sizes after a 10-min rest in the sitting position, and the values reported are the means of the two measurements. The waist circumference was measured by a plastic tape meter at the level of the umbilicus by trained physicians.

All participants completed the semi-quantitative food-frequency questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) studies \[[@CR39]\] and the Minnesota Leisure Time Physical Activity questionnaire \[[@CR40]\].

From January to November 2014, patients underwent a blood sample analysis and a follow-up medical examination by their general practitioners. Information on the vital status of each patient and the causes of death of those who died was collected from the demographic files of the town of residence or death.

The laboratory methods have been described previously \[[@CR37], [@CR38]\]. All samples were run blindly.

Mediterranean diet (MED) score {#Sec5}
------------------------------

The validated EPIC food questionnaire assessed the average frequency and portion intake of 148 foods consumed during the 12 months prior to enrolment \[[@CR39]\]. For each food item, the participants had to mark if the food or dish was consumed or not during the previous year. For all food items consumed, the subjects had to select their typical portion size with the help of photographs, the consumption frequency and the time period (day, week, month or year), which suited them best. Questions about the type of fat for cooking were also included. A dietician, blinded to the study details, checked all questionnaires for completeness, internal coherence, and plausibility. In case of uncertain answers, patients were interviewed by the dietician.

The reliability of the reported energy intake was assessed by calculating the ratio of estimated energy intake to predicted basal metabolic rate, using age- and sex-specific formulas derived by Schofiled \[[@CR41]\]. Subjects with a ratio \<0.88 were classified as under-reporters \[[@CR42]\].

The MED score, assessed in accordance to Trichopoulou et al. \[[@CR1], [@CR7]\], included 9 components and ranged from 0 (minimum conformity) to 9 (maximum conformity). Energy-adjusted intakes at or above the sex-specific median intake for healthy foods or nutrients were given 1 point \[fruits and nuts, legumes, vegetables (excluding potatoes), grains, fish, and monounsaturated fat---saturated fat ratio\]; intakes lower than the sex-specific median intake for unhealthy food were given 1 point \[dairy and meat\] and alcohol consumption within sex-specific ranges was given 1 point (10--30 and 5--25 g/day for men and women, respectively). The original alcohol consumption proposed for men was 10--50 g/day \[[@CR1], [@CR7]\]; it was reduced to 10--30 g/day, in line with Italian guideline \[[@CR43]\].

The intakes were adjusted for total energy by using the residual method \[[@CR44]\].

The MED score was analyzed both as continuous variable (per 1-unit increase) and categorical variable: low- (0--3 units), medium- (4--5 units), and high-adherence (6--9 units).

Definitions {#Sec6}
-----------

The baseline CV risk score was estimated with the Framingham risk score \[[@CR45]\]. A score \<10 defined low-risk individuals.

The physical activity level was calculated as the product of the duration and frequency of each activity (in hours/week), weighted by an estimate of the metabolic equivalent of the activity and summed for the activities performed \[[@CR40]\].

The diagnosis of CV disease was based on documented events that were recorded by the general practitioners (i.e. angina, previous myocardial infarction, coronary artery by-pass graft or another invasive procedure to treat coronary artery disease, transient ischemic attack, stroke, gangrene, amputation, vascular surgery, intermittent claudication, absent foot pulses and abnormal brachial and posterior tibial blood pressure using Doppler techniques).

The underlying cause of death was available for all the deceased patients and was obtained from the death certificate and coded according to the ICD-9 (International Classification of Diseases, Ninth Revision). Deaths due to CV diseases corresponded to ICD codes 410--414 (coronary artery diseases), 430--438 (strokes), 440 (peripheral artery diseases) and other ICD codes between 390--459 and 798.1 (other CV diseases).

Statistical analyses {#Sec7}
--------------------

The distributions of alcohol intake, fasting insulin, triglycerides and CRP values were skewed. The characteristics of the cohort according to the MED score were analyzed by ANOVA, Kruskal--Wallis tests (for not-normally distributed variables) or the χ^2^-test, as appropriate.

To test for a linear dose--response relation, the MED score was considered as continuous variables per 1-point increment. In addition, the HR were calculated by comparing categorical variable: low, medium, and high adherence to the Mediterranean diet.

Survival data were modeled through Cox-proportional-hazards regression, by estimating the hazard ratio (HR) and its 95 % confidence intervals (CI), with successive degrees of adjustments. The model 1 was adjusted for age, sex, BMI as continuous variables; the model 2 was additionally adjusted for actual smoking (1 = yes; 0 = no) and values of systolic and diastolic blood pressure, fasting glucose, total and HDL-cholesterol (continuous); the model 3 was additionally adjusted for education (3 categories: primary schools, secondary schools, university), living in a rural area (1 = yes; 0 = no), METs (h/week), and baseline CV score (continuous variable).

Separate analyses were performed for total mortality, CV mortality and incidence of CV events. In all these analyses, individuals in the first category of MED score (low adherence) were considered as the reference group, and the other groups were introduced as dummy variables.

Sensitivity analyses in order to minimize the possibility that diet was changed in response to morbidity were also ran after excluding individuals with CV disease or diabetes at baseline. Finally, analyses were repeated after the exclusion of under-reporters.

Results {#Sec8}
=======

The characteristics of individuals with CV risk \<10 and ≥10 were quite different (Table [1](#Tab1){ref-type="table"}).Table 1Clinical and laboratory characteristics of the cohort by baseline CV risk scoreCV risk score \<10CV risk score ≥10pNumber897761Age (years)52.0 ± 5.057.6 ± 4.8\<0.001Males (%)57.634.6\<0.001Living in a rural area (%)42.438.00.07University (%)9.94.6Secondary school (%)21.313.9Primary school (%)68.881.5\<0.001Current smokers (%)14.335.1\<0.001METS (h/week)\*22.2 ± 10.320.6 ± 10.40.002BMI (kg/m^2^)25.8 ± 4.427.5 ± 4.7\<0.001Waist circumference (cm)89.4 ± 12.593.7 ± 13.2\<0.001Systolic blood pressure (mmHg)127.5 ± 13.0141.0 ± 15.9\<0.001Diastolic blood pressure (mmHg)81.1 ± 8.685.9 ± 9.5\<0.001Fasting glucose (mg/dl)99.4 ± 16.7111.4 ± 40.4\<0.001Fasting insulin (µU/ml)\*\*8.1 ± 4.49.3 ± 5.4\<0.001Total cholesterol (mg/dl)203.9 ± 36.0232.3 ± 40.3\<0.001HDL cholesterol (mg/dl)62.1 ± 14.258.4 ± 12.1\<0.001Triglycerides (mg/dl)\*\*122.1 ± 69.8159.4 ± 109.7\<0.001CRP (mg/l)\*\*2.2 ± 5.03.2 ± 6.4\<0.001CV risk score6.3 ± 2.017.1 ± 7.3\<0.001CV diseases at baseline (%)012.0\<0.001Statin use (%)2.06.6\<0.001Aspirin use (%)1.010.5\<0.001Mean ± SDp values obtained by ANOVA or the χ^2^-test, as appropriate*CV* cardiovascular, *CRP* C-reactive protein\* Metabolic equivalent of activity (h/week)\*\* p values obtained by the Kruskal--Wallis test

During a mean follow-up of 12-year, 220 individuals died, 84 of deaths were due to CV causes, and 125 new CV events were recorded by the general practitioners. Overall, individuals who died during follow-up, showed a worse metabolic pattern at baseline: they were more frequently male and showed a significantly higher age, BMI, waist circumference, fasting glucose, total cholesterol and triglycerides and lower HDL cholesterol (data not shown).

Mean and median MED score values were 3.7 and 4, respectively. Out of all participants, 768 (46.3 %) showed a low adherence, 685 (41.3 %) a medium adherence, and 205 (12.4 %) a high adherence to the Mediterranean diet (Table [2](#Tab2){ref-type="table"}). The number of under-reporters was 138 (8.3 %). Among the three groups of adherence to the Mediterranean diet, the percentage of under-reporters did not differ (8.1, 8.7 and 8.4 % in the low-, medium-, and high-adherent groups, respectively).Table 2Characteristics of the cohort by CV risk and MED score group0--34--5≥6p0--34--5≥6pNumber40637911236230693Age (years)51.9 ± 5.452.0 ± 4.652.1 ± 4.70.9657.7 ± 4.957.5 ± 4.857.7 ± 4.40.81Males (%)56.958.358.00.9236.536.919.40.004Living in a rural area (%)44.641.437.50.3640.334.340.90.23University (%)7.610.815.24.44.65.4Secondary school (%)21.920.820.513.314.415.1Primary school (%)70.468.364.30.1882.381.179.60.98Current smokers (%)15.811.917.00.2030.240.935.50.02METS (h/week)^\*^22.7 ± 11.221.6 ± 9.722.1 ± 10.20.3420.6 ± 10.520.7 ± 10.120.0 ± 10.10.87BMI (kg/m^2^)26.0 ± 4.625.7 ± 4.325.2 ± 4.20.2227.8 ± 4.727.8 ± 4.925.6 ± 3.8\<0.001Waist circumference (cm)89.7 ± 12.689.4 ± 12.688.0 ± 11.90.4694.9 ± 12.692.2 ± 13.487.1 ± 12.7\<0.001Systolic blood pressure (mmHg)127.6 ± 13.4127.0 ± 12.5128.8 ± 13.30.45141.1 ± 16.2141.2 ± 15.9139.9 ± 14.60.77Diastolic blood pressure (mmHg)81.8 ± 8.580.1 ± 8.481.6 ± 9.40.0186.1 ± 9.585.8 ± 9.685.2 ± 8.80.66Fasting glucose (mg/dl)99.5 ± 16.199.9 ± 18.797.3 ± 11.00.35120.0 ± 53.0105.7 ± 23.097.3 ± 11.6\<0.001Fasting insulin (µU/ml)\*\*8.3 ± 5.07.9 ± 3.87.8 ± 3.20.439.7 ± 6.49.2 ± 4.67.8 ± 2.60.007Total cholesterol (mg/dl)203.0 ± 35.5205.4 ± 36.1202.3 ± 37.90.57231.1 ± 43.8231.2 ± 37.4240.6 ± 34.60.10HDL cholesterol (mg/dl)62.2 ± 14.561.7 ± 14.063.1 ± 13.90.6858.0 ± 11.958.2 ± 12.160.5 ± 12.60.18Triglycerides (mg/dl)\*\*121.8 ± 71.1124.0 ± 73.9117.2 ± 48.20.81165.9 ± 135.4154.5 ± 82.3150.7 ± 68.50.48CRP (mg/l)\*\*2.1 ± 3.32.5 ± 6.81.7 ± 2.10.713.6 ± 8.32.9 ± 4.12.5 ± 2.80.13CV risk score6.3 ± 2.06.3 ± 2.06.3 ± 1.90.9017.2 ± 8.116.9 ± 6.717.3 ± 6.00.80Total caloric intake (kcal/day)2169.3 ± 671.62058.4 ± 668.62126.5 ± 597.10.062022.6 ± 663.02025.6 ± 700.41964.8 ± 592.60.73Vegetables (g/day)\*\*170.6 ± 90.6203.3 ± 95.7250.0 ± 144.9\<0.001157.5 ± 90.0195.9 ± 100.9241.8 ± 145.9\<0.001Legumes (g/day)\*\*10.8 ± 11.318.1 ± 14.621.2 ± 14.6\<0.00114.2 ± 16.218.2 ± 15.720.9 ± 14.2\<0.001Fruits and nuts (g/day)\*\*254.3 ± 157.8412.5 ± 194.8576.1 ± 286.1\<0.001273.8 ± 145.9425.2 ± 218.5560.2 ± 154.8\<0.001Dairy products (g/day)\*\*213.8 ± 185.4169.4 ± 235.196.1 ± 84.0\<0.001255.8 ± 222.4154.2 ± 135.497.6 ± 78.5\<0.001Cereals (g/day)\*\*209.4 ± 134.4233.2 ± 118.0265.5 ± 104.6\<0.001183.5 ± 123.8212.6 ± 94.7257.9 ± 90.7\<0.001Meats and meat products (g/day)170.1 ± 116.7138.3 ± 64.1118.1 ± 49.1\<0.001143.8 ± 72.1139.1 ± 76.6112.6 ± 46.8\<0.001Fish (g/day)\*\*24.5 ± 21.338.1 ± 21.955.3 ± 35.1\<0.00124.8 ± 20.138.4 ± 25.852.3 ± 34.9\<0.001Monounsaturated: saturated fat ratio1.4 ± 0.31.6 ± 0.31.9 ± 0.3\<0.0011.4 ± 0.31.6 ± 0.32.0 ± 0.3\<0.001Alcohol (g/day)\*\*21.1 ± 25.017.5 ± 20.617.4 ± 18.50.3116.4 ± 24.816.5 ± 22.612.3 ± 11.80.32Mean ± SDp values obtained by ANOVA or the χ^2^-test, as appropriate*CV* cardiovascular, *CRP* C-reactive protein\* Metabolic equivalent of activity (h/week)\*\* p values obtained by the Kruskal--Wallis test

In both groups (CV risk \<10 and ≥10), the dietary pattern improved with increased adherence to the Mediterranean diet, as expected (Table [2](#Tab2){ref-type="table"}). Values of BMI, waist circumference, fasting glucose and insulin significantly decreased from low to high diet adherence only in participants with CV risk ≥10 (Table [2](#Tab2){ref-type="table"}).

Modeled as a continuous variable, the MED score predicted incident CV events in individuals with CV risk \<10 and ≥10, while it was inversely associated with all-cause and CV mortality in the low-risk group only (Table [3](#Tab3){ref-type="table"}). When the MED score was categorically modeled, the number of events decreased linearly with increasing adherence to the Mediterranean diet (Table [4](#Tab4){ref-type="table"}). Because of the presence of few events in the categories 4--5 and 6--9, the 95 % CI were large.Table 3Association of MED score as continuous variable with outcomes by Cox-regression modelsMED scoreAllCV risk score \<10CV risk score ≥10Incident CV events Number1254778HR95 % CIpHR95 % CIpHR95 % CIpCrude0.830.73--0.930.0020.800.66--0.980.030.850.73--0.990.04Model 10.840.74--0.940.0050.800.66--0.980.030.860.74--1.010.06Model 20.830.74--0.940.0040.800.65--0.990.040.850.72--0.990.04Model 30.840.74--0.950.0050.790.65--0.970.030.850.72--0.990.04CV mortality Number843450HR95 % CIpHR95 % CIpHR95 % CIpCrude0.830.71--0.960.010.750.59--0.950.020.890.73--1.080.24Model 10.860.73--0.990.040.760.59--0.960.020.950.78--1.160.61Model 20.870.75--1.020.090.740.58--0.950.020.960.78--1.180.70Model 30.880.75--1.020.090.750.58--0.960.020.940.76--1.150.53All-cause mortality Number22090130HR95 % CIpHR95 % CIpHR95 % CIpCrude0.910.83--0.990.030.830.72--0.960.010.970.86--1.090.56Model 10.930.85--1.020.120.840.72--0.970.011.020.91--1.160.71Model 20.940.85--1.100.170.840.72--0.970.021.020.90--1.150.75Model 30.940.85--1.030.200.830.72--0.960.011.020.90--1.150.81Model 1: adjusted for age, sex, BMIModel 2: adjusted for age, sex, BMI, smoking habits, systolic and diastolic blood pressure, fasting glucose, total and HDL-cholesterolModel 3: adjusted for age, sex, BMI, smoking habits, systolic and diastolic blood pressure, fasting glucose, total and HDL-cholesterol, rural area, exercise level, baseline CV risk score and educationTable 4Association of MED score as categorized variable with outcomes by Cox-regression modelsMediterranean diet scoreAllScore 0--3Score 4--5Score 6--9Number768685205Incident CV events724211HRHR; 95 % CI; pHR; 95 % CI; pCrude10.65; 0.44--0.95; 0.030.57; 0.30--1.07; 0.08Model 110.68; 0.46--0.99; 0.050.60; 0.32--1.14; 0.12Model 210.67; 0.45--0.98; 0.040.58; 0.31--1.11; 0.10Model 310.68; 0.46--1.00; 0.050.59; 0.31--1.12; 0.11CV mortality49287HRHR; 95 % CI; pHR; 95 % CI; pCrude10.63; 0.40--1.00; 0.050.52; 0.24--1.16; 0.11Model 110.65; 0.41--1.03; 0.070.65; 0.30--1.45; 0.30Model 210.68; 0.42--1.09; 0.110.69; 0.31--1.54; 0.37Model 310.68; 0.42--1.09; 0.110.69; 0.31--1.54; 0.37All-cause mortality1168222HRHR; 95 % CI; pHR; 95 % CI; pCrude10.78; 0.59--1.03; 0.080.70; 0.44--1.10; 0.12Model 110.79; 0.59--1.05; 0.100.83; 0.52--1.31; 0.42Model 210.79; 0.59--1.05; 0.110.84; 0.53--1.34; 0.47Model 310.80; 0.60--1.06; 0.120.85; 0.54--1.35; 0.50CV risk score \<10Number406379112Incident CV events28163HRHR; 95 % CI; pHR; 95 % CI; pCrude10.61; 0.33--1.12; 0.110.38; 0.12--1.26; 0.11Model 110.62; 0.34--1.15; 0.130.40; 0.12--1.31; 0.13Model 210.62; 0.33--1.16; 0.140.41; 0.12--1.35; 0.14Model 310.61; 0.33--1.14; 0.120.38; 0.11--1.27; 0.12CV mortality21103HRHR; 95 % CI; pHR; 95 % CI; pCrude10.50; 0.24--1.07; 0.070.51; 0.15--1.71; 0.28Model 110.52; 0.24--1.11; 0.090.55; 0.16--1.86; 0.34Model 210.45; 0.21--0.97; 0.040.60; 0.18--2.02; 0.41Model 310.46; 0.21--1.01; 0.050.59; 0.17--2.01; 0.40All-cause mortality50319HRHR; 95 % CI; pHR; 95 % CI; pCrude10.65; 0.42--1.02; 0.060.64; 0.31--1.30; 0.22Model 110.66; 0.42--1.04; 0.070.67; 0.33--1.37; 0.27Model 210.65; 0.41--1.02; 0.060.68; 0.33--1.38; 0.28Model 310.65; 0.41--1.03; 0.060.66; 0.32--1.35; 0.26CV risk score ≥10Number36230693Incident CV events44268HRHR; 95 % CI; pHR; 95 % CI; pCrude10.70; 0.43--1.14; 0.140.71; 0.33--1.50; 0.37Model 110.71; 0.44--1.16; 0.170.76; 0.35--1.63; 0.48Model 210.69; 0.42--1.13; 0.140.72; 0.33--1.55; 0.40Model 310.71; 0.43--1.16; 0.180.68; 0.31--1.45; 0.32CV mortality28184HRHR; 95 % CI; pHR; 95 % CI; pCrude10.74; 0.41--1.35; 0.330.54; 0.19--1.54; 0.25Model 110.73; 0.40--1.33; 0.300.81; 0.28--2.34; 0.70Model 210.79; 0.43--1.44; 0.440.81; 0.28--2.37; 0.70Model 310.70; 0.37--1.29; 0.260.76; 0.26--2.20; 0.61All-cause mortality665113HRHR; 95 % CI; pHR; 95 % CI; pCrude10.90; 0.62--1.29; 0.560.74; 0.41--1.35; 0.33Model 110.89; 0.62--1.28; 0.541.06; 0.58--1.94; 0.84Model 210.90; 0.62--1.31; 0.601.02; 0.55--1.88; 0.95Model 310.88; 0.61--1.29; 0.521.00; 0.54--1.83; 0.99Model 1: adjusted for age, sex, BMIModel 2: adjusted for age, sex, BMI, smoking habits, systolic and diastolic blood pressure, fasting glucose, total and HDL-cholesterolModel 3: adjusted for age, sex, BMI, smoking habits, systolic and diastolic blood pressure, fasting glucose, total and HDL-cholesterol, rural area, exercise level, baseline CV risk score and education

Results did not significantly changed after excluding either patients with CV disease or diabetes at baseline, the under-reporters, or those on aspirin and/or on statin treatment.

Discussion {#Sec9}
==========

A high adherence to the Mediterranean nutritional pattern favorably affected life expectancy and the risk of CV events and death among middle-aged individuals with a low CV risk.

The components of the Mediterranean diet are a high ratio of monounsaturated (olive oil) to saturated fat; moderate ethanol consumption (primarily wine); high consumption of legumes, cereals, vegetables, fruits and nuts; moderate/high consumption of fish; low consumption of milk and dairy products; low consumption of meat and meat products. Therefore, it is a nutritional pattern low in saturated fat, high in monounsaturated fat, complex carbohydrates and fiber and its beneficial effects on CV events and mortality may be mediated by the antioxidant, anti-inflammatory and platelet-reducing effects of its components \[[@CR1]--[@CR33], [@CR46]\]. Furthermore, the Mediterranean diet is inversely associated with visceral adipose tissue, advanced glycation end-products and modification of circulating adipocytokines, with increase in adiponectin concentrations \[[@CR26], [@CR47]--[@CR51]\]. Finally, intervention trials with a Mediterranean-style diet reduced values of circulating inflammatory parameters, oxidized low-density lipoproteins, markers of endothelial dysfunction \[[@CR52], [@CR53]\], and the incidence of CV risk factors, type 2 diabetes and the metabolic syndrome \[[@CR54], [@CR55]\].

However, if diabetes, hypertension, hypercholesterolemia, and chronic subclinical inflammation are potential intermediates of the association between the Mediterranean diet and CV outcomes because of the effects of the dietary pattern in modifying these risk factors, the reason why an increased MED score was more favorable in our low-risk individuals with respects to individuals with a CV risk ≥10 seems not obvious.

The diagnosis of most of these conditions may affect one's diet with better adherence to dietary recommendations, but this seems not the case in our cohort, since mean intakes of food groups were similar among individuals with CV risk \<10 and ≥10 (Table [2](#Tab2){ref-type="table"}). Furthermore, the lack of a relevant attenuation of associations when these risk factors were adjusted for, and the absence of significant changes in the results after excluding from the analyses patients with CV diseases or diabetes at baseline did not support the possibility of mediation.

A possible explanation might be the increased influence of the higher levels of risk factors in individuals at higher risk, which might have obscured the relationships between outcomes and the MED score. Our individuals with a CV risk ≥10 were above all females and 5--6 years older than those with a CV risk \<10. A more complex relationship between diet and survival with age has been reported, because of a selective earlier mortality of more susceptible individuals and relative immunity of survivors. Furthermore, an increased number of deaths occurred in our patients with a CV risk ≥10 compared to those with a CV risk \<10, and an increased influence of competing causes of death may have altered the association with mortality in the former individuals. Finally, medical treatments during follow-up of the patients at higher risk could have modified these associations, thus the advancement in medical practice should be considered as a potential condition modifying survival.

Our results are in agreement with other studies which found a lower predicting role of dietary scores in older individuals \[[@CR4]\], and stronger associations in younger and healthier individuals \[[@CR7], [@CR12]--[@CR14], [@CR16], [@CR19], [@CR20], [@CR32]\].

It could be therefore hypothesized that a healthy diet is more important for the prevention of CV diseases than for its management. This is a highly debated topic and, contrarily to our results, other authors have shown that the association between the Mediterranean diet and the risk of death was three--five-fold higher among patients with CV diseases than healthy individuals \[[@CR11]\]. Even if we cannot exclude the possibility that increased CV risk factors might have attenuated the relationships between outcomes and the MED score, our data clearly suggest the importance of healthy dietary pattern in low-risk individuals, since a low adherence to the Mediterranean diet was significantly associated with unfavorable events during follow-up.

The association with the MED score appeared to be stronger for mortality from CV diseases than from all-causes, albeit the CIs were wide due to the reduced number of events. This was in line with other studies finding a stronger protective role of the Mediterranean diet against CV death \[[@CR7], [@CR8], [@CR15], [@CR16], [@CR25]\]. Indeed, among all-cause mortality, other conditions unlikely to be related to diet, such as injuries, infections, suicides, were comprised. Once we controlled for confounding, this inverse association was robust. A realistically achievable change in diet---e.g. a 1 point increment---was associated with a significant reduction in both CV mortality and CV events in individuals with a CV risk \<10. Accordingly, most observational studies specifically focused on nonfatal CV events found a significantly reduced incidence of CV morbidity in individuals with a high adherence to the Mediterranean diet \[[@CR6], [@CR13], [@CR17], [@CR19], [@CR22], [@CR23], [@CR27], [@CR29]--[@CR31]\]. Furthermore, our results were consistent with the protective effect found in randomized trials both in primary prevention \[[@CR26]\] and against re-infarction in survivors of myocardial infarction \[[@CR2], [@CR56]\].

Several dietary factors, not included in the MED score, have been demonstrated to be important for CV risk, such as *trans* fatty acids and n-3 fatty acids. However, the omitted dietary components are likely to be associated with foods that are included in the MED score. Furthermore, the overall dietary pattern was found to be more important for health than individual nutritional components \[[@CR1], [@CR7], [@CR9], [@CR10]\] since there may be biologic interactions and complex and co-linear associations between different components of the diet and, above all, people do not consume isolated components but a complex of nutrients.

This study was performed in Northern Italy, in Piedmont, a region not facing the sea and bordering with France. This is the reason why the proportion of individuals with a high adherence to the Med score was low, differently from other areas of Italy, such as Southern Italy, where the consumptions of olive oil, fish, vegetables and legumes were higher \[[@CR29], [@CR33], [@CR46], [@CR57]\]. Nevertheless, a modest adherence to the Mediterranean diet was found to be useful in the prevention of CV events \[[@CR17]\]. Furthermore, a higher MED score did not reflect per se a true Mediterranean diet; indeed, adherence to alternative variants of the Mediterranean diet showed beneficial effects on many outcomes \[[@CR12], [@CR13], [@CR15], [@CR27], [@CR28], [@CR30], [@CR31]\], thus suggesting the possibility of adapting this dietary pattern to the geographical particularities and cultural habits of different populations.

Limitations and strengths {#Sec10}
-------------------------

Some study limitations deserve discussion. Subjects with early symptoms of CV diseases may have altered their diet and lifestyle. However, excluding cases with CV diseases at baseline and adjusting for CV risk factors did not notably alter the associations. Dietary measurement errors are almost unavoidable; however, the exclusion of under-reporting did not change the relationship between the scores and the outcomes. We only evaluated dietary pattern at baseline, and participants could have changed their diets before outcomes occurred. However, such changes would be more likely to lead to underestimation of the identified associations, as recently shown \[[@CR58]\], and dietary patterns appear to be stable, in particular adherence to the Mediterranean diet \[[@CR28]\]. Furthermore, the protective effects of the Mediterranean diet were maintained up to several years \[[@CR2]\]. Residual confounding due to the healthier lifestyle of individuals more adherent to healthy diet cannot be excluded, even if we took into account most confounders in the analyses. We cannot exclude the possibility of a survival bias, which however would have rather weakened the association between lifestyle factors and survival.

The MED score is based on cohort- and sex-specific median values across respectively 9 food categories and allocates equal weights to each component of the score, thus arbitrarily assuming the same importance for every component; indeed, it was extensively used and validated in literature \[[@CR1]--[@CR33]\]. Finally, owing to the small number of observed events, our CIs of the hazard ratios were wide.

The strengths of the present cohort study were the longitudinal design with a long follow-up; the completeness of data at follow-up, which limited the possibility of selection bias; the population-based nature; the availability of information on several variables, which were introduced as possible confounders in the analyses.

Conclusions {#Sec11}
===========

Efforts to promote adherence to a healthy dietary pattern as close as possible to the Mediterranean diet appear to be worthwhile in individuals at low CV risk.
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